Susquehanna International Group, LLP Medicinova Inc Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Medicinova Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 250,343 shares of MNOV stock, worth $325,445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250,343
Previous 250,115
0.09%
Holding current value
$325,445
Previous $365,000
10.41%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding MNOV
# of Institutions
22Shares Held
5.08MCall Options Held
0Put Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.44 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$903,4250.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA687KShares$892,5500.0% of portfolio
-
Citigroup Inc592KShares$769,5440.0% of portfolio
-
Geode Capital Management, LLC Boston, MA526KShares$683,6590.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $63.8M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...